Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
05 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/05/3127390/0/en/Revolo-Accelerates-Development-of-Orally-Administered-1104-for-Allergic-Diseases.html
10 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/10/3023631/0/en/Revolo-to-Present-at-the-2025-AAAAI-WAO-Joint-Congress.html
12 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/12/2996222/0/en/Revolo-Announces-New-Preclinical-Data-Supporting-Subcutaneous-1104-for-Atopic-Dermatitis-and-Other-Clinical-Programs.html
21 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/21/2966184/0/en/Revolo-Shares-New-Preclinical-Data-Showcasing-the-Potential-of-Sublingual-1104-in-Allergic-Disease.html
18 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/18/2948208/0/en/Revolo-Announces-New-Preclinical-Data-Further-Validating-Atopic-Dermatitis-as-a-Target-Indication-for-1104.html
07 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/07/2925958/0/en/Revolo-Announces-Fireside-Chat-at-Canaccord-Genuity-s-44th-Annual-Growth-Conference.html
ABOUT THIS PAGE